{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:19:23Z","timestamp":1740122363230,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-024-01829-4","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T05:02:08Z","timestamp":1716008528000},"page":"1647-1655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmias"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-8768","authenticated-orcid":false,"given":"Abhinav","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arati","family":"Gangadharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman A.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Peigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Charron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Lohrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayson","family":"Baman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pfenniger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaustubha","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Chicos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod","family":"Passman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley P.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"issue":"1","key":"1829_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJM199407073310108","volume":"331","author":"SH Hohnloser","year":"1994","unstructured":"Hohnloser SH, Woosley RL. Sotalol. N Engl J Med. 1994;331(1):31\u20138. https:\/\/doi.org\/10.1056\/NEJM199407073310108.","journal-title":"N Engl J Med"},{"issue":"1","key":"1829_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1\u2013156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","journal-title":"Circulation"},{"issue":"4","key":"1829_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jacep.2022.12.027","volume":"9","author":"SJ Savona","year":"2023","unstructured":"Savona SJ, Daoud EG. Something old, something new: reinventing antiarrhythmic drug loading with intravenous sotalol. JACC Clin Electrophysiol. 2023;9(4):565\u20138. https:\/\/doi.org\/10.1016\/j.jacep.2022.12.027.","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"1829_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HPC.0000000000000308","volume":"22","author":"ML Feuerborn","year":"2023","unstructured":"Feuerborn ML, et al. Protocol development and initial experience with intravenous sotalol loading for atrial arrhythmias. Crit Pathw Cardiol. 2023;22(1):1\u20134. https:\/\/doi.org\/10.1097\/HPC.0000000000000308.","journal-title":"Crit Pathw Cardiol"},{"issue":"3","key":"1829_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/jce.15819","volume":"34","author":"AY Liu","year":"2023","unstructured":"Liu AY, et al. Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. J Cardiovasc Electrophysiol. 2023;34(3):502\u20136. https:\/\/doi.org\/10.1111\/jce.15819.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"12 Suppl","key":"1829_CR6","doi-asserted-by":"publisher","first-page":"S291","DOI":"10.1046\/j.1540-8167.2003.90406.x","volume":"14","author":"S Freeland","year":"2003","unstructured":"Freeland S, Worthy C, Zolnierz M. Initiation and monitoring of class III antiarrhythmic agents. J Cardiovasc Electrophysiol. 2003;14(12 Suppl):S291\u20135. https:\/\/doi.org\/10.1046\/j.1540-8167.2003.90406.x.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1829_CR7","doi-asserted-by":"publisher","unstructured":"Steinberg BA, et al. \u201cExpedited loading with intravenous sotalol is safe and feasible-primary results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry.\u201d Heart Rhythm. 2024. https:\/\/doi.org\/10.1016\/j.hrthm.2024.02.046.","DOI":"10.1016\/j.hrthm.2024.02.046"},{"issue":"4","key":"1829_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jacep.2022.11.026","volume":"9","author":"D Lakkireddy","year":"2023","unstructured":"Lakkireddy D, et al. Feasibility and safety of intravenous sotalol loading in adult patients with atrial fibrillation (DASH-AF). JACC Clin Electrophysiol. 2023;9(4):555\u201364. https:\/\/doi.org\/10.1016\/j.jacep.2022.11.026.","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"1829_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.14740\/cr1143","volume":"11","author":"JC Somberg","year":"2020","unstructured":"Somberg JC, Vinks AA, Dong M, Molnar J. Model-informed development of sotalol loading and dose escalation employing an intravenous infusion. Cardiol Res. 2020;11(5):294\u2013304. https:\/\/doi.org\/10.14740\/cr1143.","journal-title":"Cardiol Res"},{"issue":"11","key":"1829_CR10","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"YG Yap","year":"2003","unstructured":"Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89(11):1363\u201372. https:\/\/doi.org\/10.1136\/heart.89.11.1363.","journal-title":"Heart"},{"issue":"6","key":"1829_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11936-002-0041-1","volume":"4","author":"BJ Hynes","year":"2002","unstructured":"Hynes BJ, Luck JC, Wolbrette DL, Boehmer J, Naccarelli GV. Arrhythmias in patients with heart failure. Curr Treat Options Cardiovasc Med. 2002;4(6):467\u201385. https:\/\/doi.org\/10.1007\/s11936-002-0041-1.","journal-title":"Curr Treat Options Cardiovasc Med"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-024-01829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-024-01829-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-024-01829-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:06:21Z","timestamp":1730297181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-024-01829-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":11,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1007\/s10840-024-01829-4","relation":{},"ISSN":["1572-8595"],"issn-type":[{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AS: None.AG: None.HC: None.GP: None.JC: None.GL: None.ME: None.JB: None.AP: Abbott Laboratories.KP: None.AC: None.RA: Inomagen Therapeutics; UpToDate, inc.SK: Abbott Laboritories; Baylis Medical Company, Inc; Boston Scientific Corporation (includes Guidant Corporation); GE Healthcare; HMP Education; Johnson & Johnson Health Care System, Inc; Medtronic, Inc; Northwell Health.AL: Boston Scientific Corporation (includes Guidant Corporation).RP: Janssen Pharmaceuticals, Inc; John Wiley & Sons, Inc; Johnson & Johnson; Medtronic, Inc; Wolters Kluwer Health, Inc; Wolters Kluwer NV.BK: Abbott Laboratories, Inc; Academy for Continued Healthcare Learning, LLC; AltaThera Pharmaceuticals LLC; Arrhythmia Education, Inc; Atricure, Inc; BIOTRONIK; Baylis Medical Company, Inc; BioSig Technologies; Biosense Webster, Inc; Boston Scientific Corporation; CVRx, Inc; HMP Communications LLC; MediaSphere Medical, LLC; Medical Device Business Services, Inc; Medtelligence, LLC; Medtronic, Inc; Ohio State University; Philips Healthcare; Sanofi Volta Medical Wiley-Blackwell; Wolters Kluwer Health, Inc.NV: AltaThera Pharmaceuticals LLC; Baylis Medical Company, Inc; K2P; Medtronic, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}